Market Overview:
The global Neostigmine Methylsulfate Injection market is estimated to be valued at US$ 156.75 million in 2023, with a projected compound annual growth rate (CAGR) of 4.5% from 2023 to 2030. Neostigmine Methylsulfate Injection is a medication used primarily for the reversal of neuromuscular blockade induced by muscle relaxants during surgical procedures. It acts by inhibiting the breakdown of acetylcholine, thereby ... Read more

The Neostigmine Methylsulfate Injection Market is estimated to be valued at Us$ 156.75 Mn in 2023 and is expected to exhibit a CAGR Of 4.5% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Neostigmine methylsulfate injection is an acetylcholinesterase inhibitor used to treat myasthenia gravis and to reverse the ... Read more